Impact of Body Mass Index on Biochemical Recurrence Rates After Radical Prostatectomy: An Analysis Utilizing Propensity Score Matching

Urology

Volumn 72, Issue 6, 2008, Pages 1246-1251

  Magheli, Ahmed ^a   Rais Bahrami, Soroush ^a   Trock, Bruce J ^a   Humphreys, Elizabeth B ^a   Partin, Alan W ^a   Han, Misop ^a   Gonzalgo, Mark L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CHEMICAL ANALYSIS; CONTROLLED STUDY; GLEASON SCORE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; SCORING SYSTEM; SEMINAL VESICLE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; BODY MASS INDEX; BODY WEIGHT; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 56449127787     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.01.052     Document Type: Article

References (25)

1. Allison D.B., Fontaine K.R., Manson J.E., et al. Annual deaths attributable to obesity in the United States. JAMA 282 (1999) 1530-1538
2. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
3. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
4. Calle E.E., Rodriguez C., Walker-Thurmond K., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 (2003) 1625-1638
5. Van Gaal L.F., Mertens I.L., and De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 444 (2006) 875-880
6. Carroll K.K. Obesity as a risk factor for certain types of cancer. Lipids 33 (1998) 1055-1059
7. Andersson S.O., Wolk A., Bergstrom R., et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 89 (1997) 385-389
8. Giovannucci E., Rimm E.B., Stampfer M.J., et al. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6 (1997) 557-563
9. Giovannucci E., Rimm E.B., Liu Y., et al. Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 95 (2003) 1240-1244
10. Mydlo J.H., Tieng N.L., Volpe M.A., et al. A pilot study analyzing PSA, serum testosterone, lipid profile, body mass index and race in a small sample of patients with and without carcinoma of the prostate. Prostate Cancer Prostatic Dis 4 (2001) 101-105
11. Amling C.L., Kane C.J., Riffenburgh R.H., et al. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology 58 (2001) 723-728
12. Amling C.L., Riffenburgh R.H., Sun L., et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22 (2004) 439-445
13. Freedland S.J., Aronson W.J., Kane C.J., et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 22 (2004) 446-453
14. Freedland S.J., Grubb K.A., Yiu S.K., et al. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. J Urol 174 (2005) 919-922
15. Hsing A.W., Chua Jr. S., Gao Y.T., et al. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 93 (2001) 783-789
16. Yip I., Heber D., and Aronson W. Nutrition and prostate cancer. Urol Clin North Am 26 (1991) 403-411 x
17. Ung J.O., Richie J.P., Chen M.H., et al. Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. Urology 60 (2002) 458-463
18. Carter H.B., Epstein J.I., and Partin A.W. Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease. Urology 53 (1999) 126-130
19. Rubin D.B. On principles for modeling propensity scores in medical research. Pharmacoepidemiol Drug Saf 13 (2004) 855-857
20. Rubin D.B., and Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics 52 (1996) 249-264
21. Newcomer L.M., Stanford J.L., Blumentstein B.A., et al. Temporal trends in rates of prostate cancer-declining incidence of advanced disease, 1974 to 1994. J Urol 158 (1997) 1427-1430
22. Bassett W.W., Cooperberg M.R., Sadetsky N., et al. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology 66 (2005) 1060-1065
23. Freedland S.J., Isaacs W.B., Mangold L.A., et al. Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years. Clin Cancer Res 11 (2005) 2883-2888
24. Dagnelie P.C., Schuurman A.G., Goldbohm R.A., et al. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 93 (2004) 1139-1150
25. Freedland S.J., Sokoll L.J., Platz E.A., et al. Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy. J Urol 174 (2005) 1266-1270